Navigation Links
Clarient Acquires Applied Genomics, Inc.
Date:12/21/2009

action was Stradling Yocca Carlson & Rauth. AGI's legal adviser on the transaction was Balch & Bingham LLP and its financial adviser on the transaction was Aquilo Partners, L.P.

About Pulmotype®

Pulmotype is a five antibody immunohistochemistry (IHC) test that can be used to aid in the histological distinction between adenocarcinoma and squamous cell carcinoma in non-small cell lung cancer (NSCLC) tumor specimens. The histologic classification of non-small cell lung tumors has gained clinical relevance because newly developed targeted therapies show different clinical effectiveness or toxicity dependent upon the histology of the tumor. There is currently no other widely accepted molecular-based tool to help distinguish the different histological types.

Pulmotype was developed with a 551 patient surgical specimen lung carcinoma retrospective cohort and was validated on three independent cohorts in over a thousand clinical cases. Pulmotype can play an immediate role to pathologists in complementing the morphological assessment of lung types resulting in a more accurate diagnosis and more informed therapeutic decisions.

Conference Call and Slides

Clarient will hold a conference call today to discuss the AGI acquisition with analysts and investors. The call will include a period for questions and answers. To access the slides associated with the call, please log into the Webcast.

Date: Monday, December 21, 2009

Time: 5:00 p.m. Eastern

Call-in Number: 1-877-941-8416 (domestic) 1-480-629-9808 (international)

Conference ID Number: 4196272

Webcast: www.clarientinc.c
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
2. Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
3. Clarient Announces CFO Transition Plan
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Cepheid (Nasdaq: ... an update to Xpert® Carba-R, with the addition ... OXA-232.  The on-demand, molecular test also detects and ... carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and ... as CROs or Superbugs, are a growing and ...
(Date:7/29/2015)... , July 29, 2015  Mylan N.V. (NASDAQ: ... clearance from the European Commission under the European Union ... Company plc (NYSE: PRGO ; TASE).  ... commented, "Today marks yet another important milestone in the ... as further affirmation of the sound industrial logic of ...
(Date:7/29/2015)... , July 29, 2015  Efforts to improve working ... of pharmaceutical firms in North America ... is that an effective working capital management will ease ... patent cliffs. Big pharma companies expect to invest in ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... Satellite Symposium -, SOUTH SAN FRANCISCO, Calif., ... ), a biopharmaceutical company focused,on oncology, today announced ... prostate cancer patients from its Phase 1 study ... 2008 Genitourinary (GU) Cancers,Symposium, a meeting of the ...
... a landmark study,electronically published today in the American ... test for detecting TB infection,QuantiFERON(R)-TB Gold (QFT(TM)), has ... the conventional tuberculin skin test (TST) at predicting,which ... TB,disease. This study has important implications for the ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 2Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 3Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 4Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients 5Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 2Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 3Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control 4
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order ... with autism, Little City took a proactive stance and began planning the Children’s Village ... grant provides valuable support to building the third home. , “We are very pleased ...
(Date:7/29/2015)... ... 29, 2015 , ... Attorneys representing American families in national talcum powder lawsuits ... now features a page dedicated to news related to pending talcum powder lawsuits, as ... Powder Lawsuit News page was launched with eight initial articles. , “We decided ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Since the late 1970s, Dr. Cottrell has been making predictions about the economy, ... Earth, documents many of these prognostications. He warns that extreme weather conditions and ...
(Date:7/29/2015)... , ... July 29, 2015 , ... " mybody ” ... look at small, medium and large businesses making an impact in their industry. Andrew ... with viewers how these advanced probiotic skincare products are designed to strengthen the skin’s ...
(Date:7/29/2015)... Charlotte, North Carolina (PRWEB) , ... July 29, ... ... that MetLife, Inc ., a global provider of life insurance, annuities, employee ... Adventure Team Challenge North Carolina inclusive sporting event taking place in Charlotte, ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... Maureen Salamon HealthDay Reporter , THURSDAY, April 28 ... in her early forties when she developed anorexia nervosa, and ... the middle of a disorder like that, you don,t know ... said. Luckily, Hodgin sought the care of a therapist ...
... arthritis may find themselves taking on a more active role ... an ongoing relationship with a primary healthcare (PHC) provider, according ... current issue of Medical Care , the study is ... a regular primary healthcare provider and patient activation, a growing ...
... MD The Association for Research in Vision and ... of distinguished fellows. The title of Fellow of ARVO ... to the Association. By accepting this honor, ARVO ... models and mentors for individuals pursuing careers in vision ...
... Association for Research in Vision and Ophthalmology (ARVO) is pleased ... will be acknowledged at the ARVO 2011 Annual Meeting, May ... Medal: Robert E. Anderson, MD, PhD, FARVO, Mildred Weisenfeld Award ... FEBOpht, FARVO, Friedenwald Award: James T. Rosenbaum, MD, FARVO, Cogan ...
... during proton treatments for pediatric cancer patients provides for ... radiation compared to standard diagnostic X-rays and cone beam ... Cancer Imaging and Radiation Therapy Symposium in Atlanta. The ... Oncology (ASTRO) and the Radiological Society of North America ...
... with fluorodeoxyglucose positron emission tomography (FDG-PET) images results ... different treatment options in head and neck cancer ... research presented today, at the Cancer Imaging and ... co-sponsored by the American Society for Radiation Oncology ...
Cached Medicine News:Health News:Bringing Partner Into Anorexia Treatment May Aid Recovery 2Health News:Bringing Partner Into Anorexia Treatment May Aid Recovery 3Health News:Ongoing relationship with care provider key for patients with a chronic condition: UBC study 2Health News:2011 ARVO Fellows announced 2Health News:2011 ARVO Award recipients honored at annual meeting 2Health News:2011 ARVO Award recipients honored at annual meeting 3Health News:Proton imaging provides more accuracy, less radiation to pediatric cancer patients 2
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... is light weight state-of-the-art precision ... design is adaptable to a ... Classic Stepper features a secure ... clockwise and counter-clockwise rotation with ...
Simply squeeze the trigger for free motion in any direction, guide the probe to the desired position, and release the trigger to hold it in place....
Floor stand stabilizer system...
Medicine Products: